New cream aims to scratch the itch of eczema sufferers
Symptom relief
Not yet recruiting
This study tests a cream called roflumilast for reducing itch in people with mild to moderate atopic dermatitis (eczema). About 40 participants aged 12 and older will use the cream daily for 4 weeks and report their itch and other skin sensations through a phone app. The goal is …
Phase: PHASE4 • Sponsor: Integrative Skin Science and Research • Aim: Symptom relief
Last updated May 17, 2026 05:34 UTC